Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-α1 and herpes simplex thymidine kinase followed by ganciclovir

Human Gene Therapy

Volumn 7, Issue 1, 1996, Pages 1-10

  Santodonato, Laura ^a   Ferrantini, Maria ^a   Gabriele, Lucia ^a   Proietti, Enrico ^a   Venditti, Massimo ^a   Musiani, Piero ^b   Modesti, Andrea ^b   Modica, Alessandro ^b   Lupton, Stephen D ^c   Belardelli, Filippo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c Targeted Genetics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1 INTERFERON; GANCICLOVIR; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CONTROLLED STUDY; FRIEND LEUKEMIA; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; IMMUNE RESPONSE; INTRATUMORAL DRUG ADMINISTRATION; MALE; METASTASIS; MOUSE; NONHUMAN; SURVIVAL TIME; TUMOR CELL; TUMOR REJECTION;

ANIMALS; CELL LINE; CLONE CELLS; FRIEND MURINE LEUKEMIA VIRUS; GANCICLOVIR; GENE EXPRESSION; IMMUNE SYSTEM; INTERFERON-ALPHA; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MALE; MICE; MICE, INBRED DBA; MICE, NUDE; NEOPLASM METASTASIS; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029877634     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.1-1     Document Type: Article

References (34)

1. AFFABRIS, E., JEMMA, C., and ROSSI, G.B. (1982). Isolation of interferon-resistant variants of Friend erythroleukemia cells: effects of interferon and ouabain. Virology 120, 441-452.
2. ALLIONE, A., CONSALVO, M., NANNI, P., LOLLINI, P-L., CAVALLO, F., GIOVARELLI, M., FORNI, M., GULINO, A., COLOMBO, M.P., DELLABONA, P., HOCK, H., BLANKENSTEIN, T., ROSENTHAL, F.M., GANSBACHER, B., BOSCO, M.C., MUSSO, T., GUSELLA, L., and FORNI, G. (1994). Immunizing and curative potential of replicating and nonreplicating murine mammary adenocardinoma cells engineered with Interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor α, granulocyte, macrophaghe colony-stimulating factor, and γ-interferon gene or admixed with conventional adjuvants. Cancer Res. 54, 6022-6026.
3. ANDERSON, W.F. (1994). Gene therapy for cancer. Hum. Gene Ther. 5, 1-2.
4. BARBA, D., HARDIN, J., RAY, J., and GAGE, F.H. (1993). Thymidine kinase-mediated killing of rat brain tumors. J. Neurosurg. 79, 729-735.
5. BELARDELLI, F., GRESSER, I., MAURY, C., DUVILLARD, P., PRADE, M., and MAUNOURY, M.T. (1983). Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. III. Inhibition of growth and necrosis of tumor implanted subcutaneously. Int. J. Cancer 31, 649-653.
6. BELARDELLI, F., FERRANTINI, M., MAURY, C., SANTURBANO, L., and GRESSER, I. (1984). Biologic and biochemical differences between in vitro and in vivo passaged Friend erythroleukemia cells. I. Tumorigenicity and capacity to metastasize. Int. J. Cancer. 34, 389-395.
7. BELARDELLI, F., GESSANI, S., PROIETTI, E., LOCARDI, C., BORGHI, P., WATANABE, Y., KAWADE, Y., and GRESSER, I. (1987). Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons. J. Gen. Virol. 68, 2203-2212.
8. CARUSO, M., PANIS, Y., GAGANDEEP, S., HOUSSIN, D., SALZMANN, J.L., and KLATZMANN, D. (1993). Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA 90, 7024-7028.
9. CHEN, S.H., CHEN, X.H.L., WANG, Y., KOSAI, K.I., FINEGOLD, M.J., RICH, S.S., and WOO, S.L.C. (1995). Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc. Natl. Acad. Sci. USA 92, 2577-2581.
10. CONNOR, J., BANNERJI, R., SAITO, S., HESTON, W., FAIR, W., and GILBOA, E. (1993). Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells. J. Exp. Med. 177, 1127-1134.
11. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
12. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539-3543.
13. FERRANTINI, M., PROIETTI, E., SANTODONATO, L., GABRIELE, L., PERETTI, M., PLAVEC, I., MEYER, F., KAIDO, T., GRESSER, I., and BELARDELLI, F. (1993). α1-Interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: Antitumor therapy by means of interferon-producing cells. Cancer Res. 53, 1107-1112.
14. + T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-γ-producing TS/A cells. J. Immunol. 153, 4604-4615.
15. GOLUMBEK, P.T., LAZENBY, A.J., LEVITSKY, H.I., JAFFEE, E.M., KARASUYAMA, H., BAKER, M., and PARDOLL, D.M. (1991). Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254, 713-716.
16. GOLUMBEK, P.T., HAMZEH, F.M., JAFFEE, E.M., LEVITSKY, H., LIETMAN, P.S., and PARDOLL, D.M. (1992). Herpes Simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines. J. Immunother. 12, 224-230.
17. GRESSER, I., MAURY, C., CARNAUD, C., DE MAYER, E., MAUNOURY, M.T., and BELARDELLI, F. (1990). Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases. Int. J. Cancer. 46, 468-474.
18. GRESSER, I., CARNAUD, C., MAURY, C., SALA, A., EID, P., WOODROW, D., MAUNOURY, M.T., and BELARDELLI, F. (1991). Host humoral and cellular immune mechanism in the continued suppression of Friend erythroleukemia metastases after interferon α/β treatment in mice. J. Exp. Med. 173, 1193-1203.
19. HOCK, H., DORSCH, M., KUNZENDORF, U., UBERLA, K., QIN, Z., DIAMANTSTEIN, T., and BLANKENSTEIN, T. (1993). Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant. Cancer Res. 53, 714-716.
20. KAIDO, T., BANDU, M.T., MAURY, C., FERRANTINI, M., BELARDELLI, F., and GRESSER, I. (1995). IFNα1 gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice. Int. J. Cancer. 60, 1-9.
21. LUPTON, S.D., BRUNTON, L.L., KALBERG, V.A. and OVERELL, R.W. (1991). Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol. Cell. Biol. 11, 3374-3378.
22. MOOLTEN, F.L., and WELLS, J.M. (1990). Curability of tumors bearing Herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. 82, 297-300.
23. PORGADOR, A., TZEHOVAL, E., KATZ, A., VADAI, E., REVEL, M., FELDMAN, M., and EISENBACH, L. (1992). Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res. 52, 3679-3686.
24. PORGADOR, A., BANNERJI, R., WATANABE, Y., FELDMAN, M., GILBOA, E., and EISENBACH, L. (1993). Antimetastatic vaccination of tumor-bearing mice with two types of IFN-γ gene-inserted tumor cells. J. Immunol. 150, 1458-1470.
25. PUDDU, P., LOCARDI, C., SESTILI, P., VARANO, F., PETRINI, C., MODESTI, A., MASUELLI, L., GRESSER, I., and BELARDELLI, F. (1991). Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: Role of α/β interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells. J. Virol. 65, 2245-2253.
26. RAM, Z., CULVER, K.W., WALBRIDGE, S., BLAESE, R.M., and OLDFIELD, E.H. (1993). In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53, 83-88.
27. RAM, Z., WALBRIDGE, S., OSHIRO, E.M., VIOLA, J.J., CHIANG, Y., MUELLER, S.N., BLAESE, R.M., and OLDFIELD, E.H. (1994a). Intrathecal gene therapy for malignant leptomeningeal neoplasia. Cancer Res. 54, 2141-2145.
28. RAM, Z., WALBRIDGE, S., HEISS, J.D., CULVER, K.W., BLAESE, R.M., and OLDFIELD, E.H. (1994b). In vivo transfer of the human interleukin-2 gene: Negative tumoricidal results in experimental brain tumors. J. Neurosurg. 80, 535-540.
29. SCHIRRMAGHER, V., SHANTZ, G., CLAUER, K., KOMITOWSKI, D., ZIMMERMANN, H.-P., and LOHMANN-MATTHES, M.-L. (1979). Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastases formation in vivo. Int. J. Cancer 23, 233-244.
30. TEPPER, R.I. (1992). The tumor-cytokine transplantation assay and the antitumor activity of interleukin-4. Bone Marrow Transpl. 9 (Suppl. 1), 177-181.
31. TEPPER, R.I., and MULÉ, J.J. (1994). Experimental and clinical studies of cytokine gene-modified tumor cells. Hum. Gene Ther. 5, 153-164.
32. TOWNSEND, S.E., SU, F.W., ATHERTON, M., and ALLISON, J.P. (1994). Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res. 54, 6477-6483.
33. VILE, R.G., and HART, I.R. (1993). Use of tissue-specific expression of the Herpes Simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res. 53, 3860-3864.
34. VILE, R.G., NELSON, J.A., CASTLEDEN, S., CHONG, H., and HART, I.R. (1994). Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res. 54, 6228-6234.